CHECKPOINT THERAPEUTICS, INC. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • November 9th, 2017 • Checkpoint Therapeutics, Inc. • Pharmaceutical preparations • New York
Checkpoint Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co., Ladenburg Thalmann & Co. Inc. and H.C. Wainwright & Co., LLC (each individually an “Agent” and collectively, the “Agents”), as follows:
